How do Essure contraceptive implants affect the symptoms and quality of life of women who wear them? The association RESIST (for Mutual Aid, Support and Information Network on Tubal Sterilization), opens an online questionnaire to answer this question.

It is intended for all women aged 35 to 60, implanted or explanted with the Essure contraceptive device, whether or not they use a different method of contraception. The results of this questionnaire will be published at the end of 2021.

If you want to answer it, click on this link: Study on symptoms and quality of life with and without Essure.

Understanding the effects of the implant

The objective is to “collect comparative and representative data“, so “free and anonymous“to better understand the effects of the Essure implant.

This one, marketed in France in 2002, was withdrawn from the European market in 2017 following the declaration of numerous side effects, such as abdominal, joint, musculoskeletal and pelvic pain, uterine bleeding, fatigue or pain. memory impairment.

Read also: Essure implants: soon a registry to monitor side effects

200,000 French women still with implants

To date, more than 22,000 women have removed these implants – or explantation – but 200,000 patients are still carriers of this contraception in France.

A class action was brought before the Tribunal de Grande Instance of Paris in March 2018 and a criminal complaint was filed in April 2019, but for the time being, the responsibility of the Bayer manufacturer laboratory has not yet been recognized.

The RESIST association requests recognition of both the defect of the Essure implants and the failure to inform patients about the composition of the implants or their side effects.